UK markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.7898-0.0002 (-0.03%)
As of 11:36AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.7900
Open0.8091
Bid0.7797 x 100
Ask0.8179 x 100
Day's range0.7541 - 0.8091
52-week range0.5000 - 4.6700
Volume69,125
Avg. volume613,840
Market cap43.176M
Beta (5Y monthly)0.70
PE ratio (TTM)N/A
EPS (TTM)-2.1900
Earnings date13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.23
  • GlobeNewswire

    Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024

    STAMFORD, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will report first quarter 2024 financial results on Monday, May 13, 2024, after the U.S. markets close. The press release will be available under “Press Releases” in the Investors section of the Company’s website at www.CaraTherapeutics.com. Abo

  • GlobeNewswire

    Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

    STAMFORD, Conn., April 02, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 8:40 a.m. EDT. A webcast of the presentation can be accessed under "Events & Presentations"

  • GlobeNewswire

    Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024

    STAMFORD, Conn., March 07, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a virtual key opinion leader (KOL) event titled “Meet the NP Experts” on Wednesday, March 27, 2024, at 10:00 a.m. EDT. The event will feature a panel of leaders in the field of neuropathic pruritus who will discuss the epidemiology,